After facing criticism about its ability to effectively regulate the drug and device industries, the FDA has been working to increase regulation of drug and device manufacturers. Christine Kain and Christin Garcia discuss the implications of more regulations and possible changes to the 510(k) process for approving medical devices.
Kain and Garcia's article appears in Law360. Read more...
Related Practices
Drug & Device Litigation
Product Liability Litigation
Legal Updates
31-August-2010 - CDRH Seeks to Assure Device Makers, But Holds Ground